Home > Financial Ratios > SAMRAT PHARMACHEM

SAMRAT PHARMACHEM
Core EBITDA Growth

    Back to All Ratios
SAMRAT PHARMACHEM is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for SAMRAT PHARMACHEM
Please provide your vote to see the results

SAMRAT PHARMACHEM Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 190.99-84.21-1.87172.3626.79

What is the latest Core EBITDA Growth ratio of SAMRAT PHARMACHEM ?

The latest Core EBITDA Growth ratio of SAMRAT PHARMACHEM is 190.99 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025190.99
Mar2024-84.21
Mar2023-1.87
Mar2022172.36
Mar202126.79

How is Core EBITDA Growth of SAMRAT PHARMACHEM Trending?

Years Core EBITDA Growth % Change
Mar2025 190.99
Positive
Mar2024 -84.21
Negative
Mar2023 -1.87
Negative
Mar2022 172.36
543.37
Mar2021 26.79 -

Other Financial Ratios of SAMRAT PHARMACHEM


Compare Core EBITDA Growth ratio of peers of SAMRAT PHARMACHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM ₹62.8 Cr -1.9% -1% -44.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹419,728.0 Cr 1.3% 8.9% 6% Stock Analytics
DIVIS LABORATORIES ₹167,236.0 Cr 2.4% 6% 12.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,951.0 Cr -0.6% 9.4% 44.1% Stock Analytics
DR REDDYS LABORATORIES ₹107,765.0 Cr -0.4% 9.5% 10.5% Stock Analytics
CIPLA ₹106,033.0 Cr 1.9% 2% -8.7% Stock Analytics


SAMRAT PHARMACHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM

-1.9%

-1%

-44.9%

SENSEX

-3.8%

-2%

6.3%


You may also like the below Video Courses